This post is a brief review of a recent clinical trial investigating the use of the GLP-1 agonist Ozempic (semaglutide, Novo Nordisk) for treatment of alcohol use disorder.  The basic science, preclinical and early observational studies have been discussed in an earlier post here The study was published in the January 15, 2025 issue of … Continue reading Jeff K – Report:  GLP-1 agonist clinical trial for AUD